Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...
Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.
In 2015, when Pershing Square acquired a stake in Valeant Pharmaceuticals International, Ackman likened Valeant to a "very early-stage Berkshire Hathaway." Ackman sold his entire stake in 2017 at ...
Strides Arcolab International Ltd acquired 70% stake in Beltapharm SpA, Italy, a pharmaceutical manufacturer and 100% stake in Fabryka na Daniszewskiej sp.z o.o., (later renamed as Strides Arcolab ...
The actinic keratosis treatment market is expected to grow from USD 6.13 billion in 2024 to USD 12.28 billion by 2034, at a CAGR of 7.2%. Increasing concerns over skin cancer and advancements in ...